Combined treatment with anti-TIM3, anti-PDL1 and RT led to the promotion of T cell cytotoxicity, decreased Treg and significant tumor regression as compared with anti-PDL1 plus RT treatment [84]. The gene discussed is HAVCR2; the disease is neoplasm.